Rubing Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rubing Zhang has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
Mo Xian
10 shared publicationsJing Guo
8 shared publicationsTao Cheng
8 shared publicationsChao Sun
CAS Key Laboratory of Bio-based Materials, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao, China
7 shared publications- Huizhou Liu
CAS Key Laboratory of Biobased Materials, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao 266101, China
7 shared publications Wen Liu
7 shared publications
Latest Publications
- Open Access
- 26 June 2026
- Published by Elsevier in Sustainable Chemistry and Pharmacy
- Vol. 52
Tailoring CO2 fixation through glucose and acetone as co-substrates for mevalonate biosynthesis with high carbon atom economy
- 26 June 2026
- Published by Elsevier in Sustainable Chemistry and Pharmacy
- Vol. 52
Open AccessTailoring CO2 fixation through glucose and acetone as co-substrates for mevalonate biosynthesis with high carbon atom economy
- 11 March 2026
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 15 (4) , 1532-1543
Multistrategic Engineering of Escherichia coli for High-Level Production of 3,4-Dihydroxybutyric Acid
3,4-Dihydroxybutyric acid (3,4-DHBA) is an important precursor for the synthesis of high-value fine chemicals; however, its sustainable production in microbial hosts is limited by plasmid instability and low titers. In this study, we aimed to construct a chromosome-integrated E. coli platform for plasmid-free and inducer-free biosynthesis of 3,4-DHBA from xylose and glycerol. First, preliminary pathway reconstruction through elimination of competing routes and genomic integration of key xylose dehydrogenase increased 3,4-DHBA accumulation to 1.30 g/L. Subsequently, systematic enzyme screening identified optimal aldehyde dehydrogenase and xylonate dehydratase, and an NAD+ regeneration module was introduced to strengthen redox cofactor cycling for enhanced 3,4-DHBA production. The successful plasmid- and inducer-free biosynthesis of 3,4-DHBA was accomplished by integrating all pathway genes into the genome. Furthermore, transcriptome analysis revealed that xylose transporters were unrecognized metabolic bottlenecks, and their targeted overexpression significantly improved xylose uptake and 3,4-DHBA flux. The final strain achieved a titer of 3.08 g/L in shake flask cultivation and 46.10 g/L in fed-batch fermentation with a yield of 0.49 g/g xylose and a productivity of 0.92 g/(L·h), which are the highest values reported to date. This integrated strategy establishes a scalable and cost-effective route for 3,4-DHBA production, highlighting the value of combining pathway engineering with transportation optimization in biocatalyst design and enabling lignocellulosic biomass hydrolyzates as substrates for 3,4-DHBA production.
- 11 March 2026
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 15 (4) , 1532-1543
Multistrategic Engineering of Escherichia coli for High-Level Production of 3,4-Dihydroxybutyric Acid
3,4-Dihydroxybutyric acid (3,4-DHBA) is an important precursor for the synthesis of high-value fine chemicals; however, its sustainable production in microbial hosts is limited by plasmid instability and low titers. In this study, we aimed to construct a chromosome-integrated E. coli platform for plasmid-free and inducer-free biosynthesis of 3,4-DHBA from xylose and glycerol. First, preliminary pathway reconstruction through elimination of competing routes and genomic integration of key xylose dehydrogenase increased 3,4-DHBA accumulation to 1.30 g/L. Subsequently, systematic enzyme screening identified optimal aldehyde dehydrogenase and xylonate dehydratase, and an NAD+ regeneration module was introduced to strengthen redox cofactor cycling for enhanced 3,4-DHBA production. The successful plasmid- and inducer-free biosynthesis of 3,4-DHBA was accomplished by integrating all pathway genes into the genome. Furthermore, transcriptome analysis revealed that xylose transporters were unrecognized metabolic bottlenecks, and their targeted overexpression significantly improved xylose uptake and 3,4-DHBA flux. The final strain achieved a titer of 3.08 g/L in shake flask cultivation and 46.10 g/L in fed-batch fermentation with a yield of 0.49 g/g xylose and a productivity of 0.92 g/(L·h), which are the highest values reported to date. This integrated strategy establishes a scalable and cost-effective route for 3,4-DHBA production, highlighting the value of combining pathway engineering with transportation optimization in biocatalyst design and enabling lignocellulosic biomass hydrolyzates as substrates for 3,4-DHBA production.
- 2 February 2026
- Published by Wiley in Advanced Synthesis & Catalysis
- Vol. 368 (3)
Biocatalytic Nitration of Aromatic and Heterocyclic Compounds: Current Status and Future Prospects
Nitro compounds are widely utilized as value added pharmaceuticals and explosives, the majority of which contain a nitro group on an aromatic or heterocyclic ring. Nitration of aromatic or heterocyclic rings typically relies on well‐established chemical methods, but the harsh conditions, unsatisfying selectivity, and low efficiency need to be solved for practical application. In contrast, biocatalytic nitration offers a promising alternative in the preparation of nitro compounds with complex aromatic and heterocyclic structures. The earliest nitrifying enzymes were found in the metabolic pathways of several natural products having aromatic or heterocyclic nitro groups. With evolved and engineered nitrifying enzymes, bio‐nitration can be achieved for the preparation of a broader range of unnatural nitro group containing compounds. This study provides a comprehensive summary of the representative nitro compounds having nitro groups on the aromatic and heterocyclic rings, the associated nitrifying enzymes, and the characteristics of representative nitrifying enzymes which present specific nitration mechanisms. This study also discusses challenges with current bio‐nitration techniques and proposes future opportunities for the application of bio‐nitration as a powerful tool in the synthesis of natural and unnatural nitro compounds.
- 2 February 2026
- Published by Wiley in Advanced Synthesis & Catalysis
- Vol. 368 (3)
Biocatalytic Nitration of Aromatic and Heterocyclic Compounds: Current Status and Future Prospects
Nitro compounds are widely utilized as value added pharmaceuticals and explosives, the majority of which contain a nitro group on an aromatic or heterocyclic ring. Nitration of aromatic or heterocyclic rings typically relies on well‐established chemical methods, but the harsh conditions, unsatisfying selectivity, and low efficiency need to be solved for practical application. In contrast, biocatalytic nitration offers a promising alternative in the preparation of nitro compounds with complex aromatic and heterocyclic structures. The earliest nitrifying enzymes were found in the metabolic pathways of several natural products having aromatic or heterocyclic nitro groups. With evolved and engineered nitrifying enzymes, bio‐nitration can be achieved for the preparation of a broader range of unnatural nitro group containing compounds. This study provides a comprehensive summary of the representative nitro compounds having nitro groups on the aromatic and heterocyclic rings, the associated nitrifying enzymes, and the characteristics of representative nitrifying enzymes which present specific nitration mechanisms. This study also discusses challenges with current bio‐nitration techniques and proposes future opportunities for the application of bio‐nitration as a powerful tool in the synthesis of natural and unnatural nitro compounds.
- 19 January 2026
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 15 (2) , 798-812
Metabolic Engineering of Escherichia coli for Fumarate Production from Ethanol
Ethanol is a widely available and inexpensive commodity chemical, and can be utilized by microorganisms with high carbon yield, making it a potential alternative carbon source in fermentation. In this study, fumarate, a versatile platform chemical, was biosynthesized from ethanol via partial tricarboxylic acid (TCA) cycle and glyoxylate shunt in engineered Escherichia coli strain. To address growth deficiency of E. coli on ethanol, adaptive laboratory evolution was performed, resulting in evolved strains with improved growth and enhanced fumarate production. Knockout of citrate lyase and increased adenylate cyclase activity significantly contributed to growth improvement. Furthermore, gluconeogenesis and glyoxylate shunt were further transcriptionally activated in the evolved strain. Finally, the optimized strain Q6926 produced 31.03 mM fumarate from ethanol in fed-batch fermentation. This work represents the first demonstration of growth-coupled fumarate bioproduction from ethanol, demonstrating the feasibility of using ethanol as a sustainable feedstock for the biosynthesis of TCA cycle-derived chemicals.
- 19 January 2026
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 15 (2) , 798-812
Metabolic Engineering of Escherichia coli for Fumarate Production from Ethanol
Ethanol is a widely available and inexpensive commodity chemical, and can be utilized by microorganisms with high carbon yield, making it a potential alternative carbon source in fermentation. In this study, fumarate, a versatile platform chemical, was biosynthesized from ethanol via partial tricarboxylic acid (TCA) cycle and glyoxylate shunt in engineered Escherichia coli strain. To address growth deficiency of E. coli on ethanol, adaptive laboratory evolution was performed, resulting in evolved strains with improved growth and enhanced fumarate production. Knockout of citrate lyase and increased adenylate cyclase activity significantly contributed to growth improvement. Furthermore, gluconeogenesis and glyoxylate shunt were further transcriptionally activated in the evolved strain. Finally, the optimized strain Q6926 produced 31.03 mM fumarate from ethanol in fed-batch fermentation. This work represents the first demonstration of growth-coupled fumarate bioproduction from ethanol, demonstrating the feasibility of using ethanol as a sustainable feedstock for the biosynthesis of TCA cycle-derived chemicals.
- 25 June 2025
- Published by American Chemical Society (ACS) in ACS Sustainable Chemistry & Engineering
- Vol. 13 (26) , 10029-10038
One-Pot Biotransformation of Glycerol into Mesoxalic Acid
- 25 June 2025
- Published by American Chemical Society (ACS) in ACS Sustainable Chemistry & Engineering
- Vol. 13 (26) , 10029-10038
One-Pot Biotransformation of Glycerol into Mesoxalic Acid
- Open Access
- 15 April 2025
- Published by Springer Nature in Microbial Cell Factories
- Vol. 24 (1) , 1-11
Improved methyl supply for 5-methyltetrahydrofolate production in E. coli through a novel C1 transfer pathway
- 15 April 2025
- Published by Springer Nature in Microbial Cell Factories
- Vol. 24 (1) , 1-11
Open AccessImproved methyl supply for 5-methyltetrahydrofolate production in E. coli through a novel C1 transfer pathway
- 22 March 2025
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 197 (6) , 4176-4188
Constructing Genetically Engineered Escherichia coli for De Novo Production of L-Threo-3-Hydroxyaspartic Acid
L-threo-3-hydroxyaspartic acid (L-THA) is a non-proteinogenic amino acid that has garnered significant attention due to its diverse biological activities. However, the synthesis of L-THA through enzymatic and whole-cell catalysis requires the expensive substrate L-aspartic acid or L-asparagine, and co-substrate α-ketoglutarate, which limits their large-scale application. Here, this is the first report of engineering E. coli as a cell factory for de novo production of L-THA from glucose by fermentation. Firstly, the asnO gene encoding asparagine hydroxylases from Streptomyces coelicolor was heterologously expressed in E. coli to yield the L-THA producing strain. The formation and configuration of L-THA were characterized by LC–MS and HPLC after FDAA derivatization. Secondly, the pathway genes aspC and asnB, which encode aspartate aminotransferase and asparagine synthase, respectively, were overexpressed to enhance L-THA titer from 49.9 to 90.84 mg/L. Thirdly, the efforts were made to improve the key precursor L-aspartic acid pool by overexpressing the aspartase encoding gene aspA and knocking out aspartate kinase (AK) III encoding gene lysC. The best strain CC03 was obtained and L-THA titer reached 278.3 mg/L in a shake flask, representing an approximately 5.6-fold increase compared to the original strain. Ultimately, 2.87 g/L L-THA was obtained after 32 h fed-batch fermentation. This research underscores the potential use of E. coli fermentation as a feasible platform for de novo biosynthesis of L-THA from glucose, which is amenable to industrial application.
- 22 March 2025
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 197 (6) , 4176-4188
Constructing Genetically Engineered Escherichia coli for De Novo Production of L-Threo-3-Hydroxyaspartic Acid
L-threo-3-hydroxyaspartic acid (L-THA) is a non-proteinogenic amino acid that has garnered significant attention due to its diverse biological activities. However, the synthesis of L-THA through enzymatic and whole-cell catalysis requires the expensive substrate L-aspartic acid or L-asparagine, and co-substrate α-ketoglutarate, which limits their large-scale application. Here, this is the first report of engineering E. coli as a cell factory for de novo production of L-THA from glucose by fermentation. Firstly, the asnO gene encoding asparagine hydroxylases from Streptomyces coelicolor was heterologously expressed in E. coli to yield the L-THA producing strain. The formation and configuration of L-THA were characterized by LC–MS and HPLC after FDAA derivatization. Secondly, the pathway genes aspC and asnB, which encode aspartate aminotransferase and asparagine synthase, respectively, were overexpressed to enhance L-THA titer from 49.9 to 90.84 mg/L. Thirdly, the efforts were made to improve the key precursor L-aspartic acid pool by overexpressing the aspartase encoding gene aspA and knocking out aspartate kinase (AK) III encoding gene lysC. The best strain CC03 was obtained and L-THA titer reached 278.3 mg/L in a shake flask, representing an approximately 5.6-fold increase compared to the original strain. Ultimately, 2.87 g/L L-THA was obtained after 32 h fed-batch fermentation. This research underscores the potential use of E. coli fermentation as a feasible platform for de novo biosynthesis of L-THA from glucose, which is amenable to industrial application.
- 11 January 2024
- Published by Springer Nature in World Journal of Microbiology and Biotechnology
- Vol. 40 (2) , 1-16
Progress in research on the biosynthesis of 1,2,4-butanetriol by engineered microbes
1,2,4-butanetriol (BT) is a polyol with unique chemical properties, which has a stereocenter and can be divided into D-BT (the S-enantiomer) and L-BT (the R-enantiomer). BT can be used for the synthesis of 1,2,4-butanetriol trinitrate, 3-hydroxytetrahydrofuran, polyurethane, and other chemicals. It is widely used in the military industry, medicine, tobacco, polymer. At present, the BT is mainly synthesized by chemical methods, which are accompanied by harsh reaction conditions, poor selectivity, many by-products, and environmental pollution. Therefore, BT biosynthesis methods with the advantages of mild reaction conditions and green sustainability have become a current research hotspot. In this paper, the research status of microbial synthesis of BT was summarized from the following three aspects: (1) the biosynthetic pathway establishment for BT from xylose; (2) metabolic engineering strategies employed for improving BT production from xylose; (3) other substrates for BT production. Finally, the challenges and prospects of biosynthetic BT were discussed for future methods to improve competitiveness for industrial production.
- 11 January 2024
- Published by Springer Nature in World Journal of Microbiology and Biotechnology
- Vol. 40 (2) , 1-16
Progress in research on the biosynthesis of 1,2,4-butanetriol by engineered microbes
1,2,4-butanetriol (BT) is a polyol with unique chemical properties, which has a stereocenter and can be divided into D-BT (the S-enantiomer) and L-BT (the R-enantiomer). BT can be used for the synthesis of 1,2,4-butanetriol trinitrate, 3-hydroxytetrahydrofuran, polyurethane, and other chemicals. It is widely used in the military industry, medicine, tobacco, polymer. At present, the BT is mainly synthesized by chemical methods, which are accompanied by harsh reaction conditions, poor selectivity, many by-products, and environmental pollution. Therefore, BT biosynthesis methods with the advantages of mild reaction conditions and green sustainability have become a current research hotspot. In this paper, the research status of microbial synthesis of BT was summarized from the following three aspects: (1) the biosynthetic pathway establishment for BT from xylose; (2) metabolic engineering strategies employed for improving BT production from xylose; (3) other substrates for BT production. Finally, the challenges and prospects of biosynthetic BT were discussed for future methods to improve competitiveness for industrial production.